|
TMEM131 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.340390E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.619600E-01 |
| Normal-vs-Stage2 |
4.029400E-01 |
| Normal-vs-Stage3 |
1.397750E-01 |
| Normal-vs-Stage4 |
2.172800E-01 |
| Stage1-vs-Stage2 |
9.904800E-01 |
| Stage1-vs-Stage3 |
4.296800E-01 |
| Stage1-vs-Stage4 |
6.713600E-01 |
| Stage2-vs-Stage3 |
6.147600E-01 |
| Stage2-vs-Stage4 |
7.751800E-01 |
| Stage3-vs-Stage4 |
7.972800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.428040E-01 |
| Normal-vs-AfricanAmerican |
2.007000E-01 |
| Normal-vs-Asian |
7.861400E-01 |
| Caucasian-vs-AfricanAmerican |
7.626000E-01 |
| Caucasian-vs-Asian |
4.013600E-01 |
| AfricanAmerican-vs-Asian |
2.994200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.985900E-02 |
| Normal-vs-Female |
5.915200E-01 |
| Male-vs-Female |
4.398400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.746410E-02 |
| Normal-vs-Age(41-60Yrs) |
3.490800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.781400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.527800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.943600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.420300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.524000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.378800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.790000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.854370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.196400E-01 |
| Normal-vs-Grade 2 |
4.590600E-01 |
| Normal-vs-Grade 3 |
5.830300E-02 |
| Normal-vs-Grade 4 |
1.966170E-01 |
| Grade 1-vs-Grade 2 |
1.563450E-01 |
| Grade 1-vs-Grade 3 |
1.204250E-02 |
| Grade 1-vs-Grade 4 |
4.931900E-02 |
| Grade 2-vs-Grade 3 |
7.768100E-02 |
| Grade 2-vs-Grade 4 |
4.448000E-01 |
| Grade 3-vs-Grade 4 |
6.186400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.238400E-01 |
| Normal-vs-ccB subtype |
1.689550E-01 |
| ccA subtype-vs-ccB subtype |
3.252800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.637800E-01 |
| Normal-vs-N1 |
4.809000E-01 |
| N0-vs-N1 |
8.579000E-01 |
|
|
